PNC Financial Services Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $591K | Sell |
10,747
-2,069
| -16% | -$114K | ﹤0.01% | 1441 |
|
2025
Q1 | $906K | Buy |
12,816
+650
| +5% | +$45.9K | ﹤0.01% | 1205 |
|
2024
Q4 | $800K | Buy |
12,166
+76
| +0.6% | +$5K | ﹤0.01% | 1267 |
|
2024
Q3 | $850K | Buy |
12,090
+3,122
| +35% | +$219K | ﹤0.01% | 1243 |
|
2024
Q2 | $738K | Buy |
8,968
+1,447
| +19% | +$119K | ﹤0.01% | 1268 |
|
2024
Q1 | $657K | Sell |
7,521
-682
| -8% | -$59.6K | ﹤0.01% | 1369 |
|
2023
Q4 | $791K | Sell |
8,203
-116
| -1% | -$11.2K | ﹤0.01% | 1255 |
|
2023
Q3 | $736K | Sell |
8,319
-1,509
| -15% | -$134K | ﹤0.01% | 1269 |
|
2023
Q2 | $852K | Sell |
9,828
-1,202
| -11% | -$104K | ﹤0.01% | 1233 |
|
2023
Q1 | $1.07M | Sell |
11,030
-162
| -1% | -$15.8K | ﹤0.01% | 1119 |
|
2022
Q4 | $1.16M | Sell |
11,192
-443
| -4% | -$45.8K | ﹤0.01% | 1058 |
|
2022
Q3 | $986K | Buy |
11,635
+801
| +7% | +$67.9K | ﹤0.01% | 1129 |
|
2022
Q2 | $898K | Buy |
10,834
+2,472
| +30% | +$205K | ﹤0.01% | 1214 |
|
2022
Q1 | $644K | Buy |
8,362
+1,055
| +14% | +$81.3K | ﹤0.01% | 1485 |
|
2021
Q4 | $645K | Sell |
7,307
-249
| -3% | -$22K | ﹤0.01% | 1540 |
|
2021
Q3 | $584K | Buy |
7,556
+881
| +13% | +$68.1K | ﹤0.01% | 1518 |
|
2021
Q2 | $557K | Buy |
6,675
+291
| +5% | +$24.3K | ﹤0.01% | 1534 |
|
2021
Q1 | $482K | Sell |
6,384
-2,239
| -26% | -$169K | ﹤0.01% | 1590 |
|
2020
Q4 | $756K | Buy |
8,623
+2,481
| +40% | +$218K | ﹤0.01% | 1256 |
|
2020
Q3 | $469K | Sell |
6,142
-118
| -2% | -$9.01K | ﹤0.01% | 1399 |
|
2020
Q2 | $772K | Sell |
6,260
-569
| -8% | -$70.2K | ﹤0.01% | 1152 |
|
2020
Q1 | $577K | Buy |
6,829
+1,109
| +19% | +$93.7K | ﹤0.01% | 1218 |
|
2019
Q4 | $483K | Sell |
5,720
-25,331
| -82% | -$2.14M | ﹤0.01% | 1496 |
|
2019
Q3 | $2.09M | Sell |
31,051
-4,553
| -13% | -$307K | ﹤0.01% | 954 |
|
2019
Q2 | $3.05M | Sell |
35,604
-2,441
| -6% | -$209K | ﹤0.01% | 860 |
|
2019
Q1 | $3.38M | Sell |
38,045
-3,406
| -8% | -$303K | ﹤0.01% | 855 |
|
2018
Q4 | $3.53M | Sell |
41,451
-125
| -0.3% | -$10.6K | ﹤0.01% | 800 |
|
2018
Q3 | $4.03M | Sell |
41,576
-1,538
| -4% | -$149K | ﹤0.01% | 823 |
|
2018
Q2 | $4.06M | Buy |
43,114
+961
| +2% | +$90.5K | ﹤0.01% | 816 |
|
2018
Q1 | $3.42M | Buy |
42,153
+820
| +2% | +$66.5K | ﹤0.01% | 861 |
|
2017
Q4 | $3.69M | Sell |
41,333
-1,477
| -3% | -$132K | ﹤0.01% | 840 |
|
2017
Q3 | $3.98M | Sell |
42,810
-646
| -1% | -$60.1K | ﹤0.01% | 786 |
|
2017
Q2 | $3.95M | Buy |
43,456
+1,900
| +5% | +$173K | ﹤0.01% | 766 |
|
2017
Q1 | $3.65M | Sell |
41,556
-3,939
| -9% | -$346K | ﹤0.01% | 777 |
|
2016
Q4 | $3.77M | Sell |
45,495
-5,099
| -10% | -$422K | ﹤0.01% | 762 |
|
2016
Q3 | $4.68M | Buy |
50,594
+3,433
| +7% | +$318K | 0.01% | 678 |
|
2016
Q2 | $3.67M | Sell |
47,161
-5,296
| -10% | -$412K | ﹤0.01% | 721 |
|
2016
Q1 | $4.33M | Buy |
52,457
+7,126
| +16% | +$588K | 0.01% | 672 |
|
2015
Q4 | $4.75M | Sell |
45,331
-3,463
| -7% | -$363K | 0.01% | 633 |
|
2015
Q3 | $5.14M | Buy |
48,794
+804
| +2% | +$84.6K | 0.01% | 632 |
|
2015
Q2 | $6.56M | Sell |
47,990
-356
| -0.7% | -$48.7K | 0.01% | 613 |
|
2015
Q1 | $6.03M | Sell |
48,346
-1,217
| -2% | -$152K | 0.01% | 639 |
|
2014
Q4 | $4.48M | Buy |
49,563
+228
| +0.5% | +$20.6K | ﹤0.01% | 689 |
|
2014
Q3 | $3.56M | Buy |
49,335
+2,596
| +6% | +$187K | ﹤0.01% | 734 |
|
2014
Q2 | $2.91M | Buy |
46,739
+7,395
| +19% | +$460K | ﹤0.01% | 760 |
|
2014
Q1 | $2.68M | Sell |
39,344
-1,105
| -3% | -$75.4K | ﹤0.01% | 754 |
|
2013
Q4 | $2.85M | Sell |
40,449
-51
| -0.1% | -$3.59K | ﹤0.01% | 748 |
|
2013
Q3 | $2.92M | Sell |
40,500
-3,480
| -8% | -$251K | ﹤0.01% | 726 |
|
2013
Q2 | $2.45M | Buy |
+43,980
| New | +$2.45M | ﹤0.01% | 732 |
|